In another study, a constitutively active mutant of STING encoded by mRNA was used as an adjuvant to amplify antigen-specific CD8+ T-cell responses induced by mRNA vaccine to inhibit TC-1 tumor growth31. Here, CD8A is linked to neoplasm.